Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study

Autor: Westin, Shannon N., Sill, Michael W., Coleman, Robert L., Waggoner, Steven, Moore, Kathleen N., Mathews, Cara A., Martin, Lainie P., Modesitt, Susan C., Lee, Sanghoon, Ju, Zhenlin, Mills, Gordon B., Schilder, Russell J., Fracasso, Paula M., Birrer, Michael J., Aghajanian, Carol
Zdroj: In Gynecologic Oncology December 2019 155(3):420-428
Databáze: ScienceDirect
Externí odkaz: